ATE203020T1 - Schwefel enthaltende heterocyclische verbindungen - Google Patents

Schwefel enthaltende heterocyclische verbindungen

Info

Publication number
ATE203020T1
ATE203020T1 AT91108581T AT91108581T ATE203020T1 AT E203020 T1 ATE203020 T1 AT E203020T1 AT 91108581 T AT91108581 T AT 91108581T AT 91108581 T AT91108581 T AT 91108581T AT E203020 T1 ATE203020 T1 AT E203020T1
Authority
AT
Austria
Prior art keywords
containing heterocyclic
heterocyclic compounds
sulfur containing
optionally substituted
sulfur
Prior art date
Application number
AT91108581T
Other languages
English (en)
Inventor
Takashi Sohda
Iwao Yamazaki
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE203020T1 publication Critical patent/ATE203020T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D337/00Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02Seven-membered rings
    • C07D337/06Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/08Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655381Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a seven-(or more) membered ring
    • C07F9/65539Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a seven-(or more) membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT91108581T 1990-05-30 1991-05-27 Schwefel enthaltende heterocyclische verbindungen ATE203020T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14194390 1990-05-30

Publications (1)

Publication Number Publication Date
ATE203020T1 true ATE203020T1 (de) 2001-07-15

Family

ID=15303749

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91108581T ATE203020T1 (de) 1990-05-30 1991-05-27 Schwefel enthaltende heterocyclische verbindungen

Country Status (8)

Country Link
EP (1) EP0460488B1 (de)
JP (2) JP2992653B2 (de)
AT (1) ATE203020T1 (de)
CA (1) CA2043468A1 (de)
DE (1) DE69132651T2 (de)
DK (1) DK0460488T3 (de)
ES (1) ES2157887T3 (de)
GR (1) GR3036836T3 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69520360T2 (de) * 1994-07-04 2001-08-09 Takeda Chemical Industries, Ltd. Phosphonsäure verbindungen imre herstellung und verwendung
TW403757B (en) * 1994-12-28 2000-09-01 Takeda Chemical Industries Ltd Optically active benzothiepin derivative, its preparation and use
WO1996039134A1 (en) * 1995-06-05 1996-12-12 Takeda Chemical Industries, Ltd. Osteogenetic promoting pharmaceutical composition
US5910492A (en) * 1995-06-05 1999-06-08 Takeda Chemical Industries, Ltd. Osteogenic promoting pharmaceutical composition
CA2226317A1 (en) * 1995-07-24 1997-02-06 Takeda Chemical Industries, Ltd. Production of optically active benzothiepin salts
HUP9903047A3 (en) * 1996-03-11 2002-12-28 G D Searle & Co Chicago Novel benzothiazepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
AU3868997A (en) 1996-08-26 1998-03-19 Takeda Chemical Industries Ltd. Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
EP0930874A2 (de) * 1996-10-09 1999-07-28 Takeda Chemical Industries, Ltd. Herstellungsverfahren für mikropartikel
WO1999065474A2 (en) * 1998-06-15 1999-12-23 Takeda Chemical Industries, Ltd. Compositions for treating cartilage disease comprising certain sulfur-containing heterocyclic compounds
EP1103552A4 (de) 1998-08-07 2003-01-15 Takeda Chemical Industries Ltd Benzothiepin-derivate, verfahren zu ihrer herstellung und ihre verwendungen
EP1105140A2 (de) * 1998-08-12 2001-06-13 Takeda Chemical Industries, Ltd. Benzothiepine verbindungen als beschleuniger der wirkung des zelldifferenzierungsinduktionsfaktors
AU4145200A (en) * 1999-05-07 2000-11-21 Takeda Chemical Industries Ltd. Cyclic compounds and uses thereof
CN1537018A (zh) 2001-05-23 2004-10-13 田边制药株式会社 一种用于软骨疾病再生治疗的组合物
EP1389468A4 (de) 2001-05-23 2007-01-10 Tanabe Seiyaku Co Zusammensetzungen zur förderung der knochenfrakturheilung
CA2637194A1 (en) 2006-01-18 2007-07-26 National University Corporation Tokyo Medical And Dental University Biomaterial for osteogenesis containing osteogenesis promoter and nanogel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636049A (en) * 1969-11-26 1972-01-18 Pfizer Isothiochroman carboxamides
DK656789A (da) * 1988-12-28 1990-06-29 Takeda Chemical Industries Ltd Benzoheterocykliske forbindelser

Also Published As

Publication number Publication date
EP0460488A1 (de) 1991-12-11
DE69132651D1 (de) 2001-08-16
CA2043468A1 (en) 1991-12-01
JPH04364179A (ja) 1992-12-16
JP3165889B2 (ja) 2001-05-14
GR3036836T3 (en) 2002-01-31
DE69132651T2 (de) 2001-10-25
JP2992653B2 (ja) 1999-12-20
DK0460488T3 (da) 2001-09-17
JPH09176154A (ja) 1997-07-08
EP0460488B1 (de) 2001-07-11
ES2157887T3 (es) 2001-09-01

Similar Documents

Publication Publication Date Title
NO904377L (no) Tricykliske karbapenemforbindelser.
DE69132651D1 (de) Schwefel enthaltende heterocyclische Verbindungen
ES2090790T3 (es) Derivados de glicolipidos.
TW256832B (de)
DE68918827D1 (de) Schwefel enthaltende heterocyclische Verbindungen.
DE68922765D1 (de) Substituierte Naphthalen-Verbindungen und diese enthaltende Flüssigkristall-Zusammensetzungen.
NO305960B1 (no) Svovelholdige og tiosubstituerte fosfonatforbindelser, farmasoeytisk preparat omfattende en slik forbindelse samt anvendelse derav
ATE115545T1 (de) Aralkylamin-verbindungen.
ATE168679T1 (de) Neue tetracyclische verbindungen
PT83334A (en) Process for the preparation of beta-lactam compounds
EP0401715A3 (de) Aminoketonverbindungen
GB8830226D0 (en) Novel compounds
ATE206699T1 (de) Uch-15-verbindungen
FI900796A0 (fi) Aralkylaminfoereningar.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee